ADC Therapeutics (ADCT) Non Operating Investment Income (2020 - 2021)
ADC Therapeutics (ADCT) posted quarterly Non Operating Investment Income of -$6.9 million for Q3 2021, down 120.5% year-on-year from $33.9 million in Q3 2020, and down 438.19% on a QoQ basis from $2.1 million in Q2 2021.
ADC Therapeutics (ADCT) Non Operating Investment Income (2020 - 2021) Analysis & Trends
ADC Therapeutics (ADCT) has reported Non Operating Investment Income for 2 consecutive years, with -$6.9 million the latest figure, recorded in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.89 Bn | 468.10 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.12 Bn | 114.87 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | - |
| 10 | ADC Therapeutics | 174.95 Mn | -56.06 Mn | 17.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -6.94 Mn |
| Sep 30, 2021 | -6.94 Mn |
| Jun 30, 2021 | 2.05 Mn |
| Jun 30, 2021 | 2.05 Mn |
| Mar 31, 2021 | 21.17 Mn |
| Mar 31, 2021 | 21.17 Mn |
| Sep 30, 2020 | 33.87 Mn |
| Sep 30, 2020 | 33.87 Mn |
| Jun 30, 2020 | -79.26 Mn |
| Jun 30, 2020 | -79.26 Mn |